Christopher Reid

Dr. Christopher Reid

Department of Science and Technology, Bryant University, Smithfield, RI, USA
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2009 in Journal of Bacteriology
Verified
Journal Article
Closed access
STSusan M. Twine
Susan M. Twine
CRChristopher Reid
Christopher Reid
AAAnnie Aubry
Annie Aubry
DMDavid McMullin
David McMullin
KFKelly M. Fulton
Kelly M. Fulton
SLSusan M. Logan
Susan M. Logan
In this study, intact flagellin proteins were purified from strains of Clostridium difficile and analyzed using quadrupole time of flight and linear ion trap mass spectrometers. Top-down studies showed the flagellin proteins to have a mass greater than that predicted from the corresponding gene sequence. These top-down studies revealed marker ions characteristic of glycan modifications. Additionally, diversity in the observed masses of glycan modifications was seen between strains. Electron transfer dissociation mass spectrometry was used to demonstrate that the glycan was attached to the flagellin protein backbone in O linkage via a HexNAc residue in all strains examined. Bioinformatic analysis of C. difficile genomes revealed diversity with respect to glycan biosynthesis gene content within the flagellar biosynthesis locus, likely reflected by the observed flagellar glycan diversity. In C. difficile strain 630, insertional inactivation of a glycosyltransferase gene (CD0240) present in all sequenced genomes resulted in an inability to produce flagellar filaments at the cell surface and only minor amounts of unmodified flagellin protein.

1 June 2012 in Carbohydrate Research
Verified
Journal Article
Closed access
CRChristopher Reid
Christopher Reid
EVEvgeny Vinogradov
Evgeny Vinogradov
JLJianjun Li
Jianjun Li
HJHarold C. Jarrell
Harold C. Jarrell
SLSusan M. Logan
Susan M. Logan
JBJean-Robert Brisson
Jean-Robert Brisson

1 January 2014 in Microbiology
Verified
Journal Article
Open access
DGDanielle Gutelius
Danielle Gutelius
KHKirsten Hokeness
Kirsten Hokeness
SLSusan M. Logan
Susan M. Logan
CRChristopher Reid
Christopher Reid
Clostridium difficile is the most common cause of enteric disease and presents a major burden on healthcare systems globally due in part to the observed rapid rise in antibiotic resistance. The ability of C. difficile to form endospores is a key feature in the organism’s pathogenesis and transmission, and contributes greatly to its resilient nature. Endospores are highly resistant to disinfection, allowing them to persist on hospital surfaces. In order for the organism to cause disease, the spores must germinate and revert to a vegetative form. While spore germination in Bacillus spp. is well understood, very little is known about this process in Clostridia. Here we report the characterization of SleC (CD0551) from C. difficile 630. Bioinformatic analysis of SleC indicated a multi-domained protein possessing a peptidoglycan-binding (PGB) domain, a SpoIID/LytB domain and an undefined N-terminal region. We have confirmed that SleC is an exo-acting lytic transglycosylase with the catalytic activity localized to the N-terminal region. Additionally, we have shown that both the N-terminal catalytic domain and the C-terminal PGB domain require muramyl-δ-lactam for substrate binding. As with carbohydrate-binding modules from cellulases and xylanases, the PGB domain may be responsible for increasing the processivity of SleC by concentrating the enzyme at the surface of the substrate.

1 December 2014 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
RMRobert Ménard
Robert Ménard
ISIan C. Schoenhofen
Ian C. Schoenhofen
LTLimei Tao
Limei Tao
AAAnnie Aubry
Annie Aubry
PBPatrice Bouchard
Patrice Bouchard
SLSusan M. Logan
Susan M. Logan
Helicobacter pylori is motile by means of polar flagella, and this motility has been shown to play a critical role in pathogenicity. The major structural flagellin proteins have been shown to be glycosylated with the nonulosonate sugar, pseudaminic acid (Pse). This glycan is unique to microorganisms, and the process of flagellin glycosylation is required for H. pylori flagellar assembly and consequent motility. As such, the Pse biosynthetic pathway offers considerable potential as an antivirulence drug target, especially since motility is required for H. pylori colonization and persistence in the host. This report describes screening the five Pse biosynthetic enzymes for small-molecule inhibitors using both high-throughput screening (HTS) and in silico (virtual screening [VS]) approaches. Using a 100,000-compound library, 1,773 hits that exhibited a 40% threshold inhibition at a 10 μM concentration were identified by HTS. In addition, VS efforts using a 1.6-million compound library directed at two pathway enzymes identified 80 hits, 4 of which exhibited reasonable inhibition at a 10 μM concentration in vitro . Further secondary screening which identified 320 unique molecular structures or validated hits was performed. Following kinetic studies and structure-activity relationship (SAR) analysis of selected inhibitors from our refined list of 320 compounds, we demonstrated that three inhibitors with 50% inhibitory concentrations (IC 50 s) of approximately 14 μM, which belonged to a distinct chemical cluster, were able to penetrate the Gram-negative cell membrane and prevent formation of flagella.

23 November 2007 in Biochemistry
Verified
Journal Article
Closed access
MCMark M. Chen
Mark M. Chen
EWEranthie Weerapana
Eranthie Weerapana
ECEwa Ciepichal
Ewa Ciepichal
JSJacek Stupak
Jacek Stupak
CRChristopher Reid
Christopher Reid
BIBarbara Imperiali
Barbara Imperiali

14 August 2004 in FEBS Letters
Verified
Journal Article
Open access
PDF file
CRChristopher Reid
Christopher Reid
NBN.T. Blackburn
N.T. Blackburn
BLB.A. Legaree
B.A. Legaree
FAF.-I. Auzanneau
F.-I. Auzanneau
ACAnthony Clarke
Anthony Clarke
The lytic transglycosylases cleave the bacterial cell wall heteropolymer peptidoglycan with the same specificity as the muramidases (lysozymes), between the N‐acetylmuramic acid and N‐acetylglucosami...